These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17019490)

  • 1. Use of generic alendronate in the treatment of osteoporosis.
    National Osteoporosis Foundation of South Africa
    S Afr Med J; 2006 Aug; 96(8):696-7. PubMed ID: 17019490
    [No Abstract]   [Full Text] [Related]  

  • 2. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Sep; 96(9):758-60. PubMed ID: 17068638
    [No Abstract]   [Full Text] [Related]  

  • 3. Generic alendronate in the treatment of osteoporosis.
    Kanfer I
    S Afr Med J; 2006 Oct; 96(10):1008-10. PubMed ID: 17164925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].
    MMW Fortschr Med; 2005 Dec; 147(49-50):74-5. PubMed ID: 16401016
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis.
    Landfeldt E; Ström O
    Bone; 2012 Oct; 51(4):637-42. PubMed ID: 22842329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Dec; 96(12):1214. PubMed ID: 17252142
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.
    van den Bergh JP; Bouts ME; van der Veer E; van der Velde RY; Janssen MJ; Geusens PP; Winkens B; Oldenhof NJ; van Geel TA
    PLoS One; 2013; 8(10):e78153. PubMed ID: 24205135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence of alendronate treatment for osteoporosis].
    Harada A
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():337-43. PubMed ID: 18161127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 10. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 11. Alendronate for the treatment of osteoporosis in men.
    Olszynski WP; Davison KS
    Expert Opin Pharmacother; 2008 Feb; 9(3):491-8. PubMed ID: 18220499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By the way, doctor. I'm 60 and have osteoporosis. My doctor is recommending Fosamax, but I'm concerned about jawbone problems. Are there any other drugs I can take?
    Robb-Nicholson C
    Harv Womens Health Watch; 2006 Dec; 14(4):8. PubMed ID: 17299880
    [No Abstract]   [Full Text] [Related]  

  • 13. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Short Term Alendronate Administration on Bone Mineral Density in Patients with Chronic Kidney Disease.
    Aggarwal HK; Jain D; Chhabra P; Yadav RK
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Jul; 39(1):5-13. PubMed ID: 30110263
    [No Abstract]   [Full Text] [Related]  

  • 16. A reappraisal of generic bisphosphonates in osteoporosis.
    Kanis JA; Reginster JY; Kaufman JM; Ringe JD; Adachi JD; Hiligsmann M; Rizzoli R; Cooper C
    Osteoporos Int; 2012 Jan; 23(1):213-21. PubMed ID: 21953472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
    Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
    An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
    Wynn RL
    Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
    Landfeldt E; Lang A; Robbins S; Ström O
    Calcif Tissue Int; 2011 Sep; 89(3):234-45. PubMed ID: 21695544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.